ALHC - NASDAQ
Alignment Healthcare, Inc.
$14.25
+7.1%Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
At a Glance
Live SnapshotAlignment Healthcare, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Strong liquidity. The company has adequate resources to meet short-term liabilities.
Debt-to-Equity Ratio
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.
Alignment Healthcare, Inc. Balance Sheet
ALHC • NASDAQ
| Alignment Healthcare, Inc. Balance Sheet | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
ASSETS | |||||||
CURRENT ASSETS | |||||||
577.9M | 432.9M | 202.9M | 409.5M | 466.6M | 207.3M | 86.5M | |
0.0 | 37.8M | 115.9M | 0.0 | 0.0 | 0.0 | 0.0 | |
577.9M | 470.7M | 318.8M | 409.5M | 466.6M | 207.3M | 86.5M | |
253.2M | 153.9M | 119.7M | 92.9M | 58.5M | 40.1M | 35.6M | |
253.2M | 153.9M | 119.7M | 92.9M | 58.5M | 40.1M | 35.6M | |
0.0 | 0.0 | 0.0 | 0.0 | 27.7M | 17.2M | 5.2M | |
0.0 | 37.1M | 45M | 42.1M | 0.0 | 0.0 | 0.0 | |
831.1M | 661.6M | 483.5M | 544.5M | 552.9M | 264.7M | 127.4M | |
NON-CURRENT ASSETS | |||||||
71.3M | 75M | 61.9M | 43M | 38.2M | 37M | 27.4M | |
32.1M | 34.8M | 34.8M | 34.8M | 29.3M | 29.3M | 29.3M | |
4.6M | 4.6M | 5.3M | 5.5M | 5.8M | 5.3M | 5.7M | |
36.6M | 39.4M | 40.1M | 40.3M | 35.1M | 34.6M | 35M | |
28.4M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
98.3M | 6.1M | 6.4M | 6M | 4.7M | 2.1M | 3.7M | |
234.6M | 120.4M | 108.3M | 89.3M | 78M | 73.8M | 66.1M | |
1.1B | 782.1M | 591.9M | 633.9M | 630.9M | 338.5M | 193.4M | |
LIABILITIES | |||||||
CURRENT LIABILITIES | |||||||
474.6M | 311.9M | 228.9M | 202.4M | 143.3M | 128.3M | 117.7M | |
474.6M | 242.5M | 170.1M | 171.9M | 17.4M | 128.3M | 117.7M | |
0.0 | 69.4M | 58.8M | 30.5M | 125.9M | 0.0 | 0.0 | |
0.0 | 0.0 | 0.0 | 27.5M | 23.9M | 25.2M | 12.5M | |
2M | 1.2M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
0.0 | 38.7M | 34.1M | 0.0 | 0.0 | 0.0 | 0.0 | |
476.5M | 351.8M | 263M | 230M | 167.2M | 153.5M | 130.3M | |
NON-CURRENT LIABILITIES | |||||||
323.2M | 321.4M | 161.8M | 160.9M | 150.6M | 144.2M | 138M | |
73.9M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.9M | |
410M | 329.3M | 170.8M | 164.6M | 157.6M | 154.4M | 141.9M | |
12.9M | 7.8M | 9M | 3.7M | 7M | 10.3M | 0.0 | |
886.5M | 681.1M | 433.8M | 394.6M | 324.8M | 307.9M | 272.2M | |
SHAREHOLDERS' EQUITY | |||||||
205K | 192K | 189K | 187K | 187K | 164K | 0.0 | |
1.2B | 1.1B | 1B | 970.2M | 888.5M | 410M | 0.0 | |
-1B | -1B | -880.3M | -732.2M | -582.7M | -379.6M | -78.7M | |
179.3M | 99.9M | 156.9M | 238.1M | 306M | 30.6M | -78.7M | |
179.3M | 101M | 158.1M | 239.3M | 306.1M | 30.6M | -78.7M | |
0.0 | 1.1M | 1.1M | 1.2M | 15K | 0.0 | 0.0 | |
SUMMARY | |||||||
1.1B | 782.1M | 591.9M | 633.9M | 630.9M | 338.5M | 193.4M | |
28.4M | 37.8M | 115.9M | 0.0 | 0.0 | 0.0 | 0.0 | |
338.1M | 329.3M | 170.8M | 164.6M | 157.6M | 154.4M | 138M | |
-239.9M | -103.6M | -32.1M | -244.9M | -309M | -52.9M | 51.5M | |
200,086,983 | 200,086,983 | 200,086,983 | 200,086,983 | 200,086,983 | 200,086,983 | 200,086,983 |
SEC Filings
ALHC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 06, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 24, 2026 | June 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 02, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | October 30, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 30, 2025 | October 30, 2025 | 2025 |
Related Guides
Continue your ALHC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.